# GHK-Cu: The Copper Peptide With Real Human Data — and a Delivery Problem

> GHK-Cu: Research Overview — bigfootpeptides — A cited literature summary of GHK-Cu, the copper-binding tripeptide with genuine controlled human trial data for topical use. Mechanism, trial results, and cited safety cautions.

**03 / RECOVERY & TISSUE REPAIR**

One of the best-studied peptides on this site in actual human skin trials, held back mainly by how hard it is to get through the skin barrier in the first place.

## The short version

GHK-Cu is a small copper-carrying peptide — three amino acids (glycine, histidine, lysine) chelated to a copper ion — that occurs naturally in the body and declines with age. As a topical cosmetic ingredient (Copper Tripeptide-1), it has more controlled human clinical trial data behind it than almost any other compound on this site: multiple placebo-controlled studies measuring collagen production, skin firmness, and wrinkle depth.

The catch is delivery. GHK-Cu is a poor fit for the skin's protective barrier, and researchers are still working out how to get more of it through — via smaller lipid-attached versions, or physically opening the skin with microneedling. Separately, some people in research communities report reconstituting it for injection, which is unapproved, unstudied territory with none of the topical safety record behind it. This page keeps those two contexts — topical cosmetic use and unapproved injectable use — clearly apart.

## What it is

GHK-Cu is the linear tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys), chelated 1:1 to a copper(II) ion through the histidine ring nitrogen, the glycine amino group, and a deprotonated backbone nitrogen — leaving the lysine side chain free to interact with cell-surface receptors. Molecular formula C14H23CuN6O4+. The GHK sequence itself occurs naturally within type I collagen and a matrix protein called SPARC/osteonectin, and free GHK circulates in human plasma, saliva, and urine at levels that fall with age, from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60 [16].

## How it works

GHK-Cu acts as both a copper chaperone and a broad signaling molecule. At very low, picomolar-to-nanomolar concentrations, it directly stimulates dermal fibroblasts to produce collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing the enzymes (matrix metalloproteinases) that build and break down the skin's structural matrix. The copper ion itself is functional, not just a passenger: it enables an enzyme, lysyl oxidase, that cross-links collagen and elastin fibers, and it carries antioxidant activity of its own.

At the genomic level, the effect is unusually broad. A 2018 gene-expression analysis found GHK modulates roughly 31.2% of measured human genes by a 50%-or-greater change threshold — 59% up, 41% down — with particularly strong activation of the ubiquitin-proteasome system, the cell's protein-quality-control machinery, plus DNA-repair and antioxidant gene sets [14].

## What the research shows

The delivery problem is the headline of a 2025 review: native GHK has poor skin permeability, which is why so much current research focuses on enhancement strategies — a fatty-acid-attached version with better permeability, and microneedle pretreatment, which let a measurable amount of GHK through skin that let essentially none through intact. The same review confirms the underlying collagen-stimulating signal is real: in treated human subjects, procollagen synthesis increased in 70% of people using topical GHK-Cu, versus 50% for vitamin C and 40% for retinoic acid, the two most established anti-aging comparators [13].

That same 70-vs-50-vs-40 result also appears in a widely cited 2015 review, alongside a broader account of GHK-Cu's effects: increased collagen, dermatan sulfate, chondroitin sulfate, and decorin production, and placebo-controlled improvements in skin laxity, clarity, fine lines, and wrinkle depth [16]. A 2011 human skin-penetration study quantified what actually gets through: over 48 hours, roughly 136 micrograms of copper per square centimeter penetrated dermatomed skin, with about 97 micrograms per square centimeter staying behind as a depot in the dermis [17].

The strongest controlled human trial for a GHK-containing product, though, isn't about skin firmness — it's about hair. A 6-month trial in 45 men with androgenetic alopecia found a GHK-containing complex increased hair count by 52.6 to 71.5 hairs versus 9.6 for placebo, a statistically significant difference, with no adverse events reported in any group [15].

## Reported effects, cautions & safety

Community reports here split cleanly by route of use, and both are anecdotal, not clinical evidence. People using topical copper-peptide serums most commonly describe firmer, tighter-feeling skin building gradually over weeks, softer fine lines after roughly six to twelve weeks of consistent use, and — often the earliest change people notice — better hydration and a plumper look within the first week or two. Scalp users report less hair shedding and thicker-feeling hair over several months, usually as a supportive step alongside other approaches. On the downside, irritation is the most common topical complaint — redness, itching, or dryness, usually tied to starting at too high a concentration — and a smaller group describes a 'purging' breakout phase or, rarely, a duller-looking effect nicknamed the copper uglies. A separate, smaller group describes reconstituting GHK-Cu for injection and reporting skin or recovery benefits; these accounts sit entirely outside the well-documented topical evidence and carry no validated human data behind them at all.

The cited cautions matter most for anyone considering that injectable route: it is unapproved and has no meaningful human safety data behind it, unlike the topical cosmetic form's clinical track record [13]. Because copper feeds the pigment-making enzyme tyrosinase, people prone to melasma or dark spots may want to be cautious about pigmentation changes. And because vitamin C, strong acids, and other low-pH actives can break apart the copper-peptide complex, a documented formulation-stability issue, the delivery-focused literature recommends keeping them separated in a skincare routine rather than layering them together [13].

## Where it fits in Recovery & Tissue Repair

GHK-Cu is the matrix-and-genome half of the two skin-leaning blends on this site. It's the mass-dominant ingredient in both [KLOW](/klow), roughly 50 of 80 milligrams in the commonly listed research-vial ratio, and [GLOW](/glow), where it's paired with BPC-157's vascular signal and, in KLOW's case, KPV's anti-inflammatory one. Compared to [BPC-157](/bpc-157) and [TB-500](/tb-500), GHK-Cu is the one compound here with genuine controlled human trial data behind its primary, topical, use — see the [full comparison](/compare) for how the evidence quality actually stacks up across all seven.

---

This is a reporter's notebook on repair-peptide research, not a clinic or a supplier — every claim here is tracked to its source, and every source is checked before it's trusted.